How Is EZZ’s US Market Strategy Shaping Up Amid Q1 Sales Dip?

middle.news 7:01pm on Thursday 30th of October, 2025 AEDT • Life Sciences Read Story

How Is EZZ’s US Market Strategy Shaping Up Amid Q1 Sales Dip?

7:01pm on Thursday 30th of October, 2025 AEDT Key Points Q1 FY26 receipts down 25.4% to $11.5 million Shift to performance-based digital marketing in US, targeting TikTok and Amazon Three new products launched, Breast Health, Women’s Bone Strength, and R-21 Ergothioneine capsules Expanded Australian pharmacy network with new wholesalers and stores Read Story

middle. Tap to Read Tap the card to read the full analysis about Ezz Life Science (ASX:EZZ) OPEN ARTICLE